MS
Monika Sachin Bhandari
About Monika Sachin Bhandari
Data last updated:
Monika Sachin Bhandari is a Director at Osaka Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma and Trading. Osaka Pharmaceuticals Private Limited reported revenue of ₹24.38 Cr (FY 2025). Earlier, Monika Sachin Bhandari was an Additional Director at Zenova Therapeutics Private Limited (2021) and Director at New Welcome Agencies Private Limited (2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Osaka Pharmaceuticals Private Limited U24231GJ2004PTC043750 | Director | 17 May 2023 | 2004 | ₹24.38 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zenova Therapeutics Private Limited U24100MH2011PTC225481 | Additional Director | 01 Mar 2021 | 2011 | ₹3.16 Cr (FY 2024) | Active |
| New Welcome Agencies Private Limited U74999MH2021PTC357121 | Director | 16 Mar 2021 | 2021 | ₹159 Cr (FY 2025) | Active |
| New Welcome Medico Private Limited U51909MH2021PTC357227 | Director | 17 Mar 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Monika Sachin Bhandari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sachin Subhashchandra Bhandari | 05102989 | Osaka Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Monika Sachin Bhandari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monika Sachin Bhandari
Monika Sachin Bhandari currently holds 1 directorship: Osaka Pharmaceuticals Private Limited (Director, since 17 May 2023, revenue ₹24.38 Cr (FY 2025)).
Monika Sachin Bhandari was first appointed on 01 Mar 2021 as Additional Director at Zenova Therapeutics Private Limited. The most recent appointment on record is 17 May 2023 at Osaka Pharmaceuticals Private Limited.
Monika Sachin Bhandari held 3 earlier board appointments: Zenova Therapeutics Private Limited (Additional Director, 01 Mar 2021 to 25 Mar 2021); New Welcome Agencies Private Limited (Director, 16 Mar 2021 to 23 Sep 2021); New Welcome Medico Private Limited (Director, from 17 Mar 2021).
The current boards of Monika Sachin Bhandari's companies include Sachin Subhashchandra Bhandari (Osaka Pharmaceuticals Private Limited).